Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kendle names new director of investor relations
Mr Lawson is responsible for expanding the company’s investor relations program to strengthen shareholder and analyst relations and ultimately grow the company’s shareholder base. Mr Lawson is based
Mr Lawson is responsible for expanding the company’s investor relations program to strengthen shareholder and analyst relations and ultimately grow the company’s shareholder base. Mr Lawson is based
Sun Pharmaceutical will use FEI’s 3D imaging solution for quality control of drug-loaded vesicles to speed up the development of new therapeutics. Cryo-transmission electron microscope (TEM) allows life
This marks the third US indication for Alimta. In 2004, Alimta has received consecutive approvals: first in combination with cisplatin as a treatment for patients with malignant pleural
The human immunodeficiency virus (HIV) treatment studies are being conducted at the Jattinder Gambhir Hospital in Punjab, India, and the Bhvani Hospital in Bihar, India. In the studies,
The goal of the joint projects with the National University of Singapore (NUS) is to profile oncology drugs in Asian populations, to identify novel biomarkers and to investigate
The Daiichi Sankyo Group currently possesses four pharmaceutical formulation plants in Japan. The Osaka plant will be closed after comprehensive evaluation of the current product line, overseas market
The company has recently filed a US patent application covering its collection of novel proteins and genes that are specifically expressed in colorectal cancer cells. Partial funding for
The laboratory will accommodate more than 100 employees focused on the discovery of important new molecules to treat serious diseases, the company said. Steven Gilman, chief scientific officer
Prior to Noven, Mr Amanatides served DSM Pharmaceuticals in several senior quality roles. Most recently, Mr Amanatides has served as senior director of quality operations and regulatory affairs,
This five-year contract was awarded by the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to develop novel vaccine adjuvant candidates that signal